According to Emergent BioSolutions
's latest financial reports the company has ยฃ76.7 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | ยฃ79.28 M | -9.57% |
2023-12-31 | ยฃ87.67 M | -83.49% |
2022-12-31 | ยฃ0.53 B | 24.45% |
2021-12-31 | ยฃ0.42 B | -6.37% |
2020-12-31 | ยฃ0.45 B | 256.2% |
2019-12-31 | ยฃ0.12 B | 44.77% |
2018-12-31 | ยฃ88.39 M | -33% |
2017-12-31 | ยฃ0.13 B | -40.05% |
2016-12-31 | ยฃ0.22 B | 5.77% |
2015-12-31 | ยฃ0.20 B | 15.47% |
2014-12-31 | ยฃ0.18 B | 65.71% |
2013-12-31 | ยฃ0.10 B | 24.04% |
2012-12-31 | ยฃ87.64 M | -6.61% |
2011-12-31 | ยฃ93.84 M | -15.3% |
2010-12-31 | ยฃ0.11 B | 74.21% |
2009-12-31 | ยฃ63.6 M | 1.91% |
2008-12-31 | ยฃ62.41 M | 17.27% |
2007-12-31 | ยฃ53.22 M | 36.42% |
2006-12-31 | ยฃ39.01 M | 85.37% |
2005-12-31 | ยฃ21.04 M | 492.37% |
2004-12-31 | ยฃ3.55 M | |
2002-12-31 | ยฃ3.05 M | -24.45% |
2001-12-31 | ยฃ4.03 M |